{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T18:03:36Z","timestamp":1695492216222},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T00:00:00Z","timestamp":1395273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092195","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T20:55:26Z","timestamp":1395348926000},"page":"e92195","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Computational and Biological Evaluation of N-octadecyl-N\u2032-propylsulfamide, a Selective PPAR\u03b1 Agonist Structurally Related to N-acylethanolamines"],"prefix":"10.1371","volume":"9","author":[{"given":"Inmaculada","family":"Moreno-Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Romero-Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Suard\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Decara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Rodr\u00edguez","family":"de Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Mac\u00edas-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ncpcardio1278","article-title":"Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease","volume":"5","author":"B Staels","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"TM Willson","year":"2000","journal-title":"J Med Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2174\/092986705774462905","article-title":"PPARs in diseases: control mechanisms of inflammation","volume":"12","author":"R Kostadinova","year":"2005","journal-title":"Curr Med Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/mol.105.010991","article-title":"Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3- yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression","volume":"68","author":"JP Singh","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"J Fu","year":"2003","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"J Fu","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"F Rodriguez de Fonseca","year":"2001","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.ddmec.2011.02.001","article-title":"Oleoylethanolamide: a new player in peripheral control of energy metabolism","volume":"7","author":"FJ Pav\u00f3n","year":"2010","journal-title":"Therapeutic implications Drug Discov Today Dis Mech"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11745-008-3217-y","article-title":"Biological functions and metabolism of oleoylethanolamide","volume":"43","author":"C Thabuis","year":"2008","journal-title":"Lipids"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"27849","DOI":"10.1074\/jbc.M404087200","article-title":"Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha)","volume":"279","author":"M Guzman","year":"2004","journal-title":"J Biol Chem"},{"key":"ref11","first-page":"76","article-title":"Oleoylethanolamide, a ligand of the peroxisome proliferator-activated receptor alpha, prevents liver injury and oxidative stress induced by Tween 20","volume":"4","author":"A Serrano","year":"2008","journal-title":"Obes Metab-Milan"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bcp.2007.08.020","article-title":"Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells","volume":"74","author":"M Nagasawa","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha","volume":"319","author":"J LoVerme","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","article-title":"Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain","volume":"133","author":"M Suardiaz","year":"2007","journal-title":"Pain"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"HA Overton","year":"2006","journal-title":"Cell Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"30429","DOI":"10.1074\/jbc.M305051200","article-title":"Activation of TRPV1 by the satiety factor oleoylethanolamide","volume":"278","author":"GP Ahern","year":"2003","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/jm0601102","article-title":"Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARalpha activation","volume":"50","author":"C Cano","year":"2007","journal-title":"J Med Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2011.11.011","article-title":"Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration","volume":"101","author":"C Reyes-Cabello","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding","volume":"22","author":"R Gomez","year":"2002","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"EG Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Morris GM, Huey R, Olson AJ (2008) Using AutoDock for ligand-receptor docking. Curr Protoc Bioinformatics Chapter 8: Unit 8 14.","DOI":"10.1002\/0471250953.bi0814s24"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ejmech.2007.02.015","article-title":"Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities","volume":"42","author":"LF da Costa Leite","year":"2007","journal-title":"Eur J Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ejmech.2007.10.011","article-title":"Antitumor studies \u2013 part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase","volume":"43","author":"HI Ali","year":"2008","journal-title":"Eur J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.270.5240.1354","article-title":"Sequence and characterization of a coactivator for the steroid hormone receptor superfamily","volume":"270","author":"SA Onate","year":"1995","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"18501","DOI":"10.1074\/jbc.M200205200","article-title":"Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors","volume":"277","author":"MM Gonzalez","year":"2002","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"26543","DOI":"10.1074\/jbc.M502463200","article-title":"Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators","volume":"280","author":"F Molnar","year":"2005","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1210\/me.2004-0534","article-title":"Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein","volume":"19","author":"H Lempiainen","year":"2005","journal-title":"Mol Endocrinol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1210\/me.2003-0072","article-title":"Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor","volume":"17","author":"MM Gonzalez","year":"2003","journal-title":"Mol Endocrinol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1073\/pnas.90.12.5723","article-title":"Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase\/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression","volume":"90","author":"SL Marcus","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1242\/dmm.009233","article-title":"Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARalpha agonist, reduces body weight gain and plasma cholesterol in rats","volume":"5","author":"JM Decara","year":"2012","journal-title":"Dis Model Mech"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2007.03.007","article-title":"The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats","volume":"54","author":"A Serrano","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbalip.2007.01.008","article-title":"Transcription coactivators for peroxisome proliferator-activated receptors","volume":"1771","author":"S Yu","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1566524033479537","article-title":"Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis","volume":"3","author":"S Yu","year":"2003","journal-title":"Curr Mol Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"S Mandard","year":"2004","journal-title":"Cell Mol Life Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T15:36:15Z","timestamp":1597592175000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092195"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Cavalli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092195","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,20]]}}}